Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Wockhardt Limited ( (IN:WOCKPHARMA) ) is now available.
Wockhardt Limited has disclosed that CFC Finlease Private Limited, a SEBI-licensed ESG rating provider, has independently assigned the company an ESG rating of 70 for the year 2025, based solely on Wockhardt’s public disclosures and other publicly available information. The company emphasized that it did not engage CFC Finlease for this rating, underscoring that the assessment is voluntary and external, which may enhance transparency for investors and other stakeholders tracking Wockhardt’s environmental, social and governance performance; the information has also been made accessible via the company’s website.
More about Wockhardt Limited
Wockhardt Limited is an India-based pharmaceutical company listed on BSE and NSE (symbol: WOCKPHARMA), operating in the healthcare and life sciences industry with a focus on manufacturing and marketing pharmaceutical products for domestic and international markets.
Average Trading Volume: 74,885
Technical Sentiment Signal: Buy
Current Market Cap: 226.8B INR
Learn more about WOCKPHARMA stock on TipRanks’ Stock Analysis page.